About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Extension of Closing Date of Entitlement Offer
October 10, 2017
Click here to read more
Post navigation
Previous Post
CEO Quarterly Update
Next Post
Phosphagenics Entitlement Offer Raises Over AUD3M
Related Posts
Phosphagenics Signs Japanese License Option Agreement and R&D Alliance
April 29, 2016
Dosing Commences for CBD Topical Osteoarthritis Study
March 1, 2022
March 2, 2022
Avecho licenses TPM® for development of enhanced cancer drugs
May 22, 2023
May 22, 2023